Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round Thursday evening:

Visa (V - Get Report) : "They should be a buy, buy, buy."

Sarepta Therapeutics (SRPT - Get Report) : "This one is too hard. I don't want to be in a battleground stock."

Flextronics (FLEX - Get Report) : "I like Flex. It's an inexpensive stock."

Novartis AG (NVS - Get Report) : "This is an inexpensive stock that you should buy and put away."

Cliffs Natural Resources (CLF - Get Report) : "I think that iron is coming back but the balance sheet is too bad."

Wynn Resorts (WYNN - Get Report) : "I think Wynn is fantastic. I take a long-term perspective."

Valeant Pharmaceuticals (VRX) : "I don't care for Valeant. They have too much debt to repay and I don't want to own the stock."

Medivation (MDVN) : "I think this one is worth a great deal. I would hold onto it."

Fortress Investments (FIG) : "I don't know what they own and that makes them too hard to own."

Valley National Bancorp (VLY - Get Report) : "I think it's a great situation and I like local banks."

AstraZeneca (AZN - Get Report) : "I don't like the growth profile, I prefer Bristol-Myers Squibb (BMY - Get Report) ."

American International Group (AIG - Get Report) : "I'm concerned. Travelers Companies (TRV - Get Report) is a better one."

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in V.